Skip to main content
SpringerLink
Log in

Why diversity is needed at every level of clinical trials, from participants to leaders

  • World View
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This article has been updated

Diversity in clinical trials must be accompanied by justice and equity, including benefits for underrepresented participants, in order to boost population health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 15 April 2024

    The version of this article initially published was an uncorrected proof; it has now been replaced by the final version.

References

  1. US Department of Health and Human Services. The Belmont Report https://go.nature.com/3mj33xy (2010).

  2. Baptiste, D.-L. et al. Nursing Open 9, 2236 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Pacheco, C. M. et al. Am. J. Public Health 103, 2152–2159 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ndugga, N., Pillai, D. & Artiga, S. Racial and Ethnic Disparities in Access to Medical Advancements and Technologies. https://go.nature.com/4arFv7b (2024).

  5. Breathett, K. & Manning, K. D. Circ. Cardiovasc. Qual. Outcomes 17, e010009 (2024).

    Article  PubMed  Google Scholar 

  6. Cullen, M. R. et al. Contemporary Clinical Trials 129, 107184 (2023).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, USA

    Khadijah Breathett

Authors
  1. Khadijah Breathett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khadijah Breathett.

Ethics declarations

Competing interests

The author declares no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Breathett, K. Why diversity is needed at every level of clinical trials, from participants to leaders. Nat Med 30, 929 (2024). https://doi.org/10.1038/s41591-024-02914-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02914-x

  • Springer Nature America, Inc.

Search

Navigation